Mycobacterium

    Cards (42)

    • What is the primary pathogenic mycobacterium discussed in the study material?
      1. tuberculosis
    • Why is it important to understand pathogenic mycobacteria?
      They are significant causes of disease in humans.
    • What are the key processes involved in the pathogenesis of mycobacteria?
      • Establishment of infection
      • Progression to disease
      • Transmission
    • What is the shape and structure of mycobacteria?
      They are unicellular and branched rods.
    • What type of staining is used for mycobacteria?
      Acid-fast staining.
    • What is the Ziehl-Neelsen stain used for?
      To stain mycobacteria.
    • What are the steps involved in the Ziehl-Neelsen staining process?
      1. Stain with carbol fuchsin.
      2. Destain with acid alcohol.
      3. Counterstain with methylene blue.
    • What color do mycobacteria stain in the Ziehl-Neelsen method?
      Red.
    • What is the significance of mycolic acid in mycobacteria?
      It contributes to the waxy cell wall, making them acid-fast.
    • How are mycobacteria classified based on their growth rate?
      • Fast growers: 1-2 days on plates (e.g., M. phlei, M. smegmatis).
      • Slow growers: several weeks to months (e.g., M. tuberculosis).
    • Which mycobacterium is closely related to tuberculosis and poses a zoonotic risk?
      1. bovis.
    • What disease does M. avium-intracellulare cause in humans?
      It is an opportunistic infection, especially common in HIV patients.
    • What disease is caused by M. leprae?
      Leprosy.
    • What is the global impact of tuberculosis?
      30,000 people die every week, and 2 billion are infected.
    • What are the common clinical manifestations of tuberculosis?
      Fever, weight loss, weakness, persistent cough.
    • What are the potential sites of TB infection in the body?
      • Central nervous system
      • Lymphatic system
      • Genitourinary system
      • Bones and joints
    • What happens to most people after a TB infection?
      They control the infection and may develop asymptomatic latent infection.
    • How does M. tuberculosis enter the body?
      Through aerosols that travel to the alveoli of the lungs.
    • What is the role of alveolar macrophages in TB infection?
      They engulf M. tuberculosis and can either clear or contain the infection.
    • What is the granulomatous response in TB infection?
      • Attracts more immune cells.
      • Damages tissue and forms granulomatous tubercle.
      • Can lead to latent infection.
    • What can happen if the granulomatous response fails to contain the bacteria?
      It can lead to reactivation of the infection.
    • What is the significance of the immune response in TB transmission?
      It is required for transmission and can damage the host.
    • What is the primary method of diagnosing TB?
      Microscopy of sputum for acid-fast rods.
    • What is the culture medium used for growing mycobacteria?
      Lowenstein-Jensen medium.
    • What is the role of PCR in TB diagnosis?
      It detects the presence of TB DNA.
    • What are the control strategies for TB?
      • Preventive vaccination.
      • Antibiotic treatment.
      • Diagnosis.
    • What is the purpose of the BCG vaccine?
      To prevent establishment of TB infection and disease.
    • What is the efficacy of the BCG vaccine in children?
      It protects against disseminated disease.
    • What is the challenge with treating the 2 billion people with asymptomatic TB infection?
      They cannot be treated effectively due to the lack of symptoms.
    • What are the first-line oral anti-TB drugs?
      • Isoniazid
      • Rifampicin
      • Ethambutol
      • Pyrazinamide
    • Why is multi-drug treatment required for TB?
      To prevent resistance development in bacteria.
    • What is the definition of MDR-TB?
      Resistant to at least rifampicin and isoniazid.
    • What is XDR-TB?
      Resistant to rifampicin, isoniazid, any fluoroquinolone, and at least one injectable second-line drug.
    • What is the treatment regimen for MDR-TB?
      • At least 4 potentially active drugs.
      • New drugs like Bedaquiline and Delaminid.
      • Repurposed drugs like Linezolid and moxifloxacin.
    • What is the global success rate for treating MDR-TB?
      55%.
    • What is the causative agent of leprosy?
      1. leprae.
    • How can M. leprae be cultured for study?
      In 9-banded armadillos and mouse footpads.
    • What percentage of individuals infected with leprosy develop clinical disease?
      5%.
    • What are the two clinical manifestations of leprosy?
      • Tuberculoid: mild disease with few bacilli.
      • Lepromatous: severe disease with many bacilli.
    • What is the primary treatment for lepromatous leprosy?
      Dapsone.